Answers are grounded in this paper and cite their sources.
The in vivo synergistic effect of various combinations of antibiotics was tested in an experimental model of lethal infection with Pseudomonas. Rats treated with saline, carbenicillin, tobramycin, gentamicin, cephalothin, or cephanone alone, with cephalothin plus tobramycin or gentamicin, or with cephanone plus tobramycin or gentamicin showed rapid ip multiplication of Pseudomonas and severe bacteremia; all animals died. In contrast, combined therapy with carbenicillin plus tobramycin or gentamicin cleared Pseudomonas from the bloodstream and the challenge site and resulted in survival. This in vivo synergy was lost when combined therapy was not given frequently during the first day of infection. Combined carbenicillin and tobramycin also had a synergistic effect on 22 of 24 strains of Pseudomonas tested in vitro for susceptibility to various combinations of antibiotics. The in vivo and in vitro activity of tobramycin against Pseudomonas was as effective as that of gentamicin. These studies indicate true in vivo synergy against this strain of Pseudomonas when carbenicillin is combined with tobramycin or gentamicin as therapy for serious pseudomonas infections, and suggest that combined therapy with carbenicillin and either tobramycin or gentamicin may be useful for certain pseudomonas infections in humans.
No takes yet. Share an insight, caveat, or question.
V. T. Andriole (1974) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: